gene therapy

With FDA filing for key gene therapy pushed back 6 months, uniQure opens the pocketbook to refresh the pipeline
Endpoints
Tue, 06/22/21 - 10:37 pm
uniQure
M&A
Corlieve Therapeutics
AMT-260
gene therapy
temporal lobe epilepsy
BioMarin's gene therapy lead jumps ship to rival biotech Vedere Bio II
Fierce Biotech
Tue, 06/22/21 - 11:11 am
Vedere Bio II
gene therapy
Biomarin
VectorY raises $38M to develop Alzheimer's, ALS gene therapies
Fierce Biotech
Tue, 06/15/21 - 11:37 pm
VectorY Therapeutics
gene therapy
ALS
Alzheimer's disease
Nightstar becomes nightmare, but Biogen has bigger fish to fry
EP Vantage
Tue, 06/15/21 - 10:30 am
Biogen
Nightstar Therapeutics
M&A
gene therapy
BIIB111
BIIB112
Novartis’ $2 Million Gene Therapy Zolgensma Shows ‘Remarkable’ Results and Offers Hope for Children with SMA
Xtalks
Tue, 06/8/21 - 12:19 pm
Novartis
Zolgensma
SMA
gene therapy
Bluebird's Zynteglo trials set to resume, putting gene therapy back on flight path to FDA filing
Fierce Pharma
Mon, 06/7/21 - 11:09 am
Bluebird Bio
Zynteglo
gene therapy
beta-thalassemia
Orchard abandons promising gene therapy for rare immune disorder
BioPharma Dive
Thu, 06/3/21 - 10:54 pm
Orchard Therapeutics
gene therapy
UniQure moves Huntington's gene therapy to next phase of key trial
BioPharma Dive
Thu, 05/27/21 - 11:54 pm
uniQure
Huntington's disease
clinical trials
gene therapy
AMT-130
Esco raises $200M to set up Boston cell and gene therapy hub
Fierce Biotech
Thu, 05/27/21 - 11:48 am
Esco Lifesciences
funding
Boston
gene therapy
cell therapy
Biogen and Ginkgo Bioworks team up to develop novel gene therapy manufacturing platform
Biopharma Reporter
Mon, 05/24/21 - 10:43 am
Biogen
Ginkgo Bioworks
gene therapy
Bluebird’s new gene therapy among three new EMA OKs ahead of FDA
Endpoints
Fri, 05/21/21 - 10:56 am
gene therapy
Bluebird Bio
EMA
GSK
Vir
COVID-19
Skysona
monoclonal antibodies
Bylvay
Roche's Spark sues gene therapy rival bluebird for using 'spark' in its marketing campaigns
Fierce Pharma
Thu, 05/20/21 - 11:15 am
Roche
Spark Therapeutics
Bluebird Bio
gene therapy
trademark
Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech
Fierce Biotech
Wed, 05/19/21 - 10:31 am
Novartis
gene therapy
Tevard Biosciences
Funding News: Three Biopharmas Score a Combined $261 Million to Advance Pipelines
BioSpace
Tue, 05/18/21 - 11:21 pm
funding
Hummingbird Biosciences
eureKARE
microbiome
Interius BioTherapeutics
cell therapy
gene therapy
Sarepta touts clean data for commercial grade Duchenne gene therapy, clearing key hurdle to PhIII
Endpoints
Tue, 05/18/21 - 11:11 am
Sarepta
Duchenne Muscular Dystrophy
clinical trials
gene therapy
Biogen gene therapy for rare eye disease falls short in key clinical trial
MedCity News
Sun, 05/16/21 - 11:26 pm
Biogen
gene therapy
clinical trials
X-linked retinitis pigmentosa
cotoretigene toliparvovec
Biogen looks to build better gene therapies through latest deal
BioPharma Dive
Tue, 05/11/21 - 11:45 am
Biogen
gene therapy
Capsigen
Using AI for Gene Therapy Design, Dyno Scoops Up $100 Million to Expand Platform
BioSpace
Thu, 05/6/21 - 11:12 pm
Dyno Therapeutics
gene therapy
funding
artificial intelligence
Gene therapies in the knee? With the help of a small herd of horses, a new startup hopes to crack osteoarthritis
Endpoints
Wed, 05/5/21 - 10:32 am
gene therapy
osteoarthritis of the knee
animal studies
Genascence
Gene therapy funding frenzy reaches Affinia as it reels in $110M in new capital
MedCity News
Mon, 05/3/21 - 11:04 pm
Affinia Therapeutics
funding
gene therapy

Pages